期刊文献+

Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms 被引量:1

原文传递
导出
摘要 The most common subtype of lung cancer is non-small cell lung cancer(NSCLC), which has a poor prognosis and seriously threatens the health of human beings. The multidisciplinary comprehensive treatment model has gradually become the mainstream of NSCLC treatment. Traditional Chinese medicine(TCM) can be used effectively either as an adjunctive therapy or alone throughout the NSCLC therapy,which has a significant impact on survival, quality of life, and reduction of toxicity. Therefore, this paper reviewed the theoretical basis, the latest clinical application, and combined treatment mechanisms in order to explore the advantage stage of TCM treatment and the synergistic therapeutic mechanisms.
出处 《Chinese Herbal Medicines》 CAS 2023年第4期509-515,共7页 中草药(英文版)
基金 supported by National Administration of Traditional Chinese Medicine: The Seventh Batch of National Traditional Chinese Medicine Experts Academic Experience Inheritance Project Tianjin Municipal Education Commission Scientific Research Plan Project (No. 2021KJ143)。
  • 相关文献

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部